4
Changes in Ownership
PRECISION BIOSCIENCES INC Filed Acc 0001209191-24-002115
Chief Medical Officer sold 21,526 shares at $0.36 ($7,749)
- Chief Medical Officer acquired 60,012 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| List Alan Chief Medical Officer | 2024-01-20 | Option exercise 10b5-1 | +60,012 | 116,508 | D: show line 1 in the form | ||
| List Alan Chief Medical Officer | 2024-01-22 | Sale 10b5-1 | −21,526 | $0.36 | $7,749 | 94,982 | D: show line 2 in the form |
| Open-market sales · 21,526 sh · avg $0.36 · $7,749 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| List Alan Chief Medical Officer | 2024-01-20 | Option exercise · Restricted Stock Units 10b5-1 | −60,012 | 119,988 | D: show line 3 in the form |
Loading xslF345X05/doc4.xml…